Skip to main content
FinSpry Logo
FinSpry
CSBR logo
CSBR
(NASDAQ)
Champions Oncology, Inc.
$5.77-- (--)
Loading... - Market loading
OverviewFinancialsForecastStatisticsDividendsHistoricalProfile

Champions Oncology (CSBR) Stock Price & Financial Analysis

Champions Oncology Stock Price Chart

Price Chart

Loading chart...

Financial Metrics & Key Statistics

Fundamental metrics, valuation ratios, and profitability indicators

Day's Range$5.65 - $6.02
52-Week High$9.63
52-Week Low$5.50
Open$5.65
Volume2.71K
Average Volume (3M)2.71K
Market Cap83.42M
Shares Outstanding14.46M
P/E Ratio (TTM)34.30
Price to Sales (P/S)1.46
Price to Book (P/B)20.51
EV/EBITDA20.72
Revenue (TTM)58.42M
Net Income (TTM)2.49M
Free Cash Flow (TTM)5.64M
EPS (TTM)$0.17
Profit Margin4.27%
Operating Margin4.22%
Return on Equity (ROE)59.78%
Debt to Equity1.26
50-Day MA$6.23
200-Day MA$6.75
52-Week Change-31.30%
Annual Dividend$0.00
Dividend Yield0.00%
Payout Ratio0.00%

Frequently Asked Questions About Champions Oncology

What is the current stock price for CSBR?

As of the latest trading session, CSBR stock trades at $5.77. The 52-week range is $5.50–$9.63, with a day range of $5.65–$6.02.

What is the P/E ratio for CSBR?

Champions Oncology's trailing P/E ratio is 34.3, meaning investors pay $34.3 for every $1 of annual earnings. Champions Oncology operates in the Healthcare sector.

Does CSBR pay dividends?

Champions Oncology does not currently pay a regular dividend. The company reinvests earnings into growth and operations. Check the Dividends tab for historical dividend information.

What do analysts recommend for CSBR?

Analyst ratings and recommendations for CSBR are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.

What is the market cap of CSBR?

Champions Oncology's market capitalization is $83.4M, classifying it as a micro-cap company. Champions Oncology operates in the Healthcare sector within the Biotechnology industry.